Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

2017
type: Class

RDF description of Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis. - http://research.umh.es/vivo/pub/articulo/177313
type: Document
rights: termsOfUse
date: 2026-08-02T04:35:21
publisher: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.
type: Anualidad
included: Unidad Mixta de Investigación en Métodos Estadísticos Avanzados en Ciencias de la Salud UMH-FISABIO 2017
date time value: 177313 pubdate
included: Instituto Centro de Investigación Operativa 2017
type: 2017
type: Document
type: Thing
related by: AutorExt:285074_2017-Artículo:177313
page end: 148
related by: AutorExt:285078_2017-Artículo:177313
has publication venue: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
included: Grupo de Investigación Aplicada en Agroquímica y Medio Ambiente 2017
ARG_2000028: 177313 vcard
type: Academic Article
included: Innovaciones en Productos Alimentarios 2017
most specific type: 2017
related by: AutorExt:285077_2017-Artículo:177313
type: Article
type: Generically Dependent Continuant
included: Interacción Persona Ordenador y Reconocimiento de Formas 2017
included: Estadística, Matemáticas e Informática 2017
type: Entity
page start: 145
most specific type: Academic Article
related by: Autor:4585-Artículo:177313
related by: AutorExt:285073_2017-Artículo:177313
related by: AutorExt:285075_2017-Artículo:177313
type: Continuant
type: Information Content Entity

Unidad Mixta de Investigación en Métodos Estadísticos Avanzados en Ciencias de la Salud UMH-FISABIO 2017
type: ResearchOrganizationReport
type: Anualidad
type: 2017
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Instituto Centro de Investigación Operativa 2017
type: InstituteReport
type: Anualidad
type: 2017
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

AutorExt:285074_2017-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

AutorExt:285078_2017-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
type: Generically Dependent Continuant
type: Entity
publication venue for: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.
type: Information Content Entity
type: Collection
type: Thing
type: Continuant
type: Journal
type: Periodical

Grupo de Investigación Aplicada en Agroquímica y Medio Ambiente 2017
type: ResearchOrganizationReport
type: Anualidad
type: 2017
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Innovaciones en Productos Alimentarios 2017
type: ResearchOrganizationReport
type: Anualidad
type: 2017
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

AutorExt:285077_2017-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Interacción Persona Ordenador y Reconocimiento de Formas 2017
type: ResearchOrganizationReport
type: Anualidad
type: 2017
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Estadística, Matemáticas e Informática 2017
type: Anualidad
type: 2017
type: DepartmentReport
type: Thing
type: ResearchReport
includes: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Autor:4585-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

AutorExt:285073_2017-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

AutorExt:285075_2017-Artículo:177313
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.